Profile
Hemanshu Shah worked as a Marketing Director at Bristol Myers Squibb Co. from 1988 to 2002.
He then worked as a Manager-Global Sales at Johnson & Johnson in 2002.
From there, he became the VP-Medical Affairs & International Development at Transgene SA. In 2003, he joined GPC Biotech, Inc. as Vice President-Commercial Operations, where he worked until 2008.
He then became the Chief Business Officer at Innate Pharma SA from 2008 to 2010.
In 2010, he worked as the Chief Operating Officer at Arog Pharmaceuticals, Inc. until 2011.
He also served as a Member-Supervisory Board at Modra Pharmaceuticals BV.
In 2012, he joined Astellas Pharma SAS as Vice President-Marketing, where he worked until 2014.
Dr. Shah holds a doctorate from Rutgers State University of New Jersey and an MBA from State University of New York at Buffalo.
Former positions of Hemanshu Shah
| Companies | Position | End |
|---|---|---|
Astellas Pharma SAS
 Astellas Pharma SAS Medical DistributorsDistribution Services Astellas Pharma SAS wholesales pharmaceutical products. The company was founded in 2005 and is headquartered in Levallois-Perret, France. | Sales & Marketing | 2013-12-31 |
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Chief Operating Officer | 2010-12-31 |
| INNATE PHARMA | Corporate Officer/Principal | 2009-12-31 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | 2007-12-31 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of Hemanshu Shah
| Rutgers State University of New Jersey | Doctorate Degree |
| State University of New York at Buffalo | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| TRANSGENE | Health Technology |
| INNATE PHARMA | Health Technology |
| Private companies | 4 |
|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Astellas Pharma SAS
Astellas Pharma SAS Medical DistributorsDistribution Services Astellas Pharma SAS wholesales pharmaceutical products. The company was founded in 2005 and is headquartered in Levallois-Perret, France. | Distribution Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Health Technology |
Modra Pharmaceuticals BV
 Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Hemanshu Shah
